抗割的前列腺癌:从发现的抵抗机制到当前的治疗方法
Thi Khanh Le1,2, Quang Hieu Duong1,2,3, Virginie Baylot1,2
1Centre de Recherche en Cancérologie de Marseille-CRCM, Inserm UMR1068, CNRS UMR7258, Aix-Marseille University U105, 13009 Marseille, France.
由于抵抗机制,割抵抗性前列腺癌 (CRPC) 构成了重大挑战. 这份审查详细介绍了CRPC的细节.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 前列腺癌 (PC) 是男性的全球领先癌症.
- 抗割前列腺癌 (CRPC) 是一个主要的临床障碍.
- 对抗雄激素剥夺疗法 (ADT) 的抗药性机制是复杂的.
研究的目的:
- 要总结CRPC的潜在抵抗机制.
- 审查目前和新兴的CRPC治疗策略.
主要方法:
- 对促进CRPC的机制的文献综述.
- 已批准的CRPC治疗方法的概述.
主要成果:
- 抗CRPC包括AR依赖和独立的途径.
- 已批准的治疗方法包括化疗,免疫疗法,辐射和PARP抑制剂.
结论:
- 了解CRPC机制对于治疗开发至关重要.
- 需要结合策略和新疗法来改善患者的治疗结果.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
相关概念视频
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
